Encapsulation: Characterization of Carbon Nanotubes for Doxorubicin Encapsulation
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F62156489%3A43210%2F16%3A43914964" target="_blank" >RIV/62156489:43210/16:43914964 - isvavai.cz</a>
Result on the web
<a href="https://www.taylorfrancis.com/books/9780429103391/chapters/10.1201/b19457-23" target="_blank" >https://www.taylorfrancis.com/books/9780429103391/chapters/10.1201/b19457-23</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Encapsulation: Characterization of Carbon Nanotubes for Doxorubicin Encapsulation
Original language description
It can be concluded that functionalized CNTs can be effectively used for diagnosis and targeted drug therapy. Even though they have been employed for delivery of a wide variety of pharmaceuticals, DOX is the most widely employed drug due to a significantdecrease of its cardiotoxic effects in nanobinding DOX.
Czech name
—
Czech description
—
Classification
Type
C - Chapter in a specialist book
CEP classification
—
OECD FORD branch
10608 - Biochemistry and molecular biology
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2016
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Book/collection name
CRC Concise Encyclopedia of Nanotechnology
ISBN
978-1-4665-8034-3
Number of pages of the result
10
Pages from-to
186-195
Number of pages of the book
1186
Publisher name
CRC Press
Place of publication
Boca Raton, Florida
UT code for WoS chapter
000445393000019